SlideShare a Scribd company logo
Short Talk : Life Table &Kaplan-Meier Method
PG Student : Dr.Pravin
PG Guide : Dr.Todkar sir
Activity Guide : Dr.Jatti sir
Purpose
1.There has been short notes on Life Tables
& Kaplan-Meier Method in PG exams
2. Short Talk is presented so that all the
PGs will be well acquainted with topic
Contents :
1.Introduction – Natural history of disease
2. Five approaches of expressing prognosis
3.Life Tables
4.Kaplan-Meier Method
Natural History of Disease
The disease results from complex interaction
between man, an agent ( or cause of disease )
and environment
Natural history of disease signifies the way in which
a disease evolves over time from the earliest stage of
its prepathogenesis phase to termination as recovery,
disability or death ,in the absence of treatment or
prevention
It is described as consisting of two phases :
Prepathogenesis (i.e. Process in environment ) &
Pathogenesis ( Process in man ) .
1. Prepathogenesis Phase : In this phase the disease
agent has not entered the human ,but factors favouring
its interaction with human host are already existing in
the environment.
2. Pathogenesis phase begins with the entry of
disease agent in the susceptible human host .
 In case of infectious diseases, the agent multiplies &
induces tissue physiological changes ,the disease
progresses through period of incubation later through
early & late pathogenesis .
The final outcome of disease may be recovery
disability or death.
NATURAL HISTORY OF DISEASE
Natural history of disease in quantitative terms :
Importance :
1.To describe severity of disease to establish
priorities for clinical services & public health
programmes .
2.Quantification is important to establish baseline for
natural history , so that as new treatments become
available, the effects can be compared.
3. It is important to identify different treatments
or management strategies for different stages of
disease.
4. Patients are often concerned about prognosis.
• Five approaches of expressing prognosis
• I. Case-fatality
• II. 5-year survival
• III. Observed Survival
• IV. Median survival Time
• V. Relative survival
Case- Fatality:
• It is defined as the number of people who die of
disease by number of people who have the disease
• Case Fatality = No. of people who die of disease/
No. of people who have disease× 100
Person years
It is total sum of number of years that each member
in study population is under observation.
The individuals are observed for different periods of
time ,the unit used for counting the observation time
is person –year.
Person years :
• Limitations: person –years : Each person year is
assumed to be equivalent to every other person year
(i.e. the risk is same in any person- year observed )
• Despite this issue , Person –years are useful as
denominators of rates of events in many situations,
as randomized trials , cohort studies
Five-Year Survival
The 5 –year survival is the percentage of patients
who are alive 5 years after treatment begins or 5
years after diagnosis.
Median Survival Time:
 It is defined as the length of time that half (50%) of
the study population survives.
Mean survival time is average of survival times
Advantages:
Median survival time is less affected by extremes ,
where as mean survival times can be significantly
affected by even single outlier
In case of median survival , we would only have to
observe the deaths of half of the group under
observation & in case mean survival have to
observe all deaths in study population.
Relative survival:
 It is defined as the ratio of observed survival in
people with the disease to expected survival if the
disease were absent.
Life Tables (Observed survival )
• The actual observed survival of patients
followed over time, based on knowledge
the interval within which event has
occurred.
• Life Tables are used for this purpose
• It is peculiar type of cohort analysis.
Hypothetical study of Treatment results (2000-2004)
Followed to 2005 ( None lost to Follow –Up)
Yr of
Treat
ment
No. of
Patients
treated
NO. ALIVE ON ANNIVERSARY OF TREATMENT
2001 2002 2003 2004 2005
2000 84 44 21 13 10 8
2001 62 31 14 10 6
2002 93 50 20 13
2003 60 29 16
2004 76 43
• Survival analysis in Patients Treated (2000-2004)
Yr of
Treat
ment
No. of
Patients
treated
NO. ALIVE AT END OF YEAR
1st Yr 2nd Yr 3rd Yr 4th Yr 5th Yr
2000 84 44 21 13 10 8
2001 62 31 14 10 6
2002 93 50 20 13
2003 60 29 16
2004 76 43
Total 375 197 71 36 16 8
Probability Of Survival For Each Year Of The Study
Total no. of patients who were alive 1 year after initiation of
treatment / Total number of patients who started treatment
1. Probability of Surviving 1st year (P1)
= 197/375 =0.525
2. Probability of Surviving 2nd year (P2)
= 71/197-43 = 0.461
3. Probability of Surviving 3rd year (P3)
= 36/71-16 = 0.655
4. Probability of Surviving 4th year (P4)
= 16/36-13 = 0.696
5. Probability of Surviving 5th year (P5)
= 8/16-6 = 0.800
Cumulative Probabilities of Surviving Different
Lengths of Time :
1. Probability of Surviving 1 year
= P1 = 0.525 = 52.5 %
2. Probability of Surviving 2 years
= P1×P2 =0.525×0.461 = =0.242
3.Probablity of Surviving 3 years
= P1×P2×P3 = 0.525×0.461×0.655 =0.159
4.Probablity of Surviving 4 years
= P1×P2×P3×P4 = 0.525×0.461×0.655×0.696 =0.800
5. Probability of Surviving 5 years
= P1×P2×P3×P4×P5 = 0.525× 0.461× 0.655 ×0.696
×0.800 = 0.088
• Survival curve for hypothetical example of patients
treated from 2000-2004 & followed until 2005
Calculating Life Table
Interval
since
beginning
treatment
Alive at
begining
of
interval
Died
during
interval
Withdrew
during
interval
No.at
risk of
dying
during
interval
Col 2-
1/2 col4
Proportion
who died
during
interval
Col3/col5
Proportion
who
didn’t die
during
interval
1- Col.6
Cumu
lative
surviv
al
x IX dx Wx I’x qx px Px
1st yr 375 178 0 375 0.475 0.525 0.525
2nd yr 197 83 43 175.5 0.473 0.527 0.277
3rd yr 71 19 16 63 0.302 0.698 0.193
4th yr 36 7 13 29.5 0.237 0.763 0.147
5th yr 16 2 6 13 0.154 0.846 0.124
• Life Table uses :
1.Finding out expectancy of life at birth or any age
2.Estimating no. of males who can marry and hence
become target group for family planning methods
Similarly number of children requiring high school
education facilities , number of old people requiring
social support can be estimated
3.Life insurance companies to fix their premiums
and polices.
4.Estimating survival rates after radiotherapy or
neurosurgery or anti malignancy treatment in the
patients
Kaplan –Meier Method
Kaplan –Meier method also known as product limit
method is statistical method used in analysis of time
to event data
Kaplan –Meier method is simplest way of
computing the survival over time in spite of all
difficulties associated with subjects or situations
It is one of the best options to be used for measuring
the fraction of subjects living after treatment
In the Kaplan-Meier method predetermined intervals
,as done in Life tables, are not used.
The exact point in time when each death or the
event of interest, occurred is identified so that each
death or event terminates the previous interval &
new interval is started & For this new row is used
in the Kaplan- Meier table.
 Survival probability for each time interval is
calculated as the number of subjects surviving
divided by number of patients at risk .
• Hypothetical example of study of six patients
analyzed by Kaplan-Meier method
• Calculating Survival Using Kaplan-Meier Method
Times to
Deaths
from
starting
Rx
(Months
)
No. Alive
at Each
Time of
death(Inclu
ding those
who died at
that time)
No .
Who
Died at
Each
Time
Proportion
who died
at That
Time
(Col.3/Col.2 )
Proportion
who
survived at
That Time
(1-Col.4)
Cumulativ
e
survival
4 6 1 0.167 0.833 0.833
10 4 1 0.250 0.750 0.625
14 3 1 0.333 0.667 0.417
24 1 1 1.000 0.000 0.000
Kaplan- Meier Method uses :
• It is used to estimate survival function based on time
to the occurrence of the event
• Life tables are less commonly used nowadays and
have been replaced with the Kaplan-Meier method.
Assumptions made is using Life tables &
Kaplan-Meier Method
There has been no change in the effectiveness of
treatment or in survivorship over calendar time.
Participants are lost to follow up. If large proportion
of the study population is lost to follow up, the
findings of study will be less valid
Third assumption is related with use of
predetermined intervals as in case of traditional life
tables
• References :
• 1.Gordis Epidemiology
• 2.Park’s Textbook of Preventive & Social Medicine
Thank You

More Related Content

What's hot

Basic survival analysis
Basic survival analysisBasic survival analysis
Basic survival analysis
Mike LaValley
 
Survival analysis
Survival analysisSurvival analysis
Survival analysis
Sanjaya Sahoo
 
Survival analysis
Survival analysisSurvival analysis
Survival analysis
Har Jindal
 
Introduction To Survival Analysis
Introduction To Survival AnalysisIntroduction To Survival Analysis
Introduction To Survival Analysis
federicorotolo
 
1.5.4 measures incidence+incidence density
1.5.4 measures incidence+incidence density1.5.4 measures incidence+incidence density
1.5.4 measures incidence+incidence density
A M
 
Survival Analysis Using SPSS
Survival Analysis Using SPSSSurvival Analysis Using SPSS
Survival Analysis Using SPSS
Nermin Osman
 
Survival analysis & Kaplan Meire
Survival analysis & Kaplan MeireSurvival analysis & Kaplan Meire
Survival analysis & Kaplan Meire
Dr Athar Khan
 
Kaplan meier survival curves and the log-rank test
Kaplan meier survival curves and the log-rank testKaplan meier survival curves and the log-rank test
Kaplan meier survival curves and the log-rank test
zhe1
 
A gentle introduction to survival analysis
A gentle introduction to survival analysisA gentle introduction to survival analysis
A gentle introduction to survival analysis
Angelo Tinazzi
 
SURVIVAL ANALYSIS.ppt
SURVIVAL ANALYSIS.pptSURVIVAL ANALYSIS.ppt
SURVIVAL ANALYSIS.ppt
mbang ernest
 
Survival analysis
Survival analysisSurvival analysis
Survival analysis
IbraahimAli3
 
2.epidemilogic measures
2.epidemilogic measures2.epidemilogic measures
2.epidemilogic measures
Sumit Prajapati
 
Application of survival data analysis introduction and discussion
Application of survival data analysis  introduction and discussionApplication of survival data analysis  introduction and discussion
Application of survival data analysis introduction and discussion
ASQ Reliability Division
 
Mortality rates & standardization
Mortality rates &  standardizationMortality rates &  standardization
Mortality rates & standardization
Vaishnavi Madhavan
 
MANOVA SPSS
MANOVA SPSSMANOVA SPSS
MANOVA SPSS
Dr Athar Khan
 
Bias and confounder
Bias and confounderBias and confounder
Bias and confounder
Reena Titoria
 
Survival analysis 1
Survival analysis 1Survival analysis 1
Survival analysis 1
KyusonLim
 
Epidemiology lecture3 incidence
Epidemiology lecture3 incidenceEpidemiology lecture3 incidence
Epidemiology lecture3 incidence
INAAMUL HAQ
 
Survival Data Analysis for Sekolah Tinggi Ilmu Statistik Jakarta
Survival Data Analysis for Sekolah Tinggi Ilmu Statistik JakartaSurvival Data Analysis for Sekolah Tinggi Ilmu Statistik Jakarta
Survival Data Analysis for Sekolah Tinggi Ilmu Statistik Jakarta
Setia Pramana
 
unmatched case control studies
unmatched case control studiesunmatched case control studies
unmatched case control studies
Mrinmoy Bharadwaz
 

What's hot (20)

Basic survival analysis
Basic survival analysisBasic survival analysis
Basic survival analysis
 
Survival analysis
Survival analysisSurvival analysis
Survival analysis
 
Survival analysis
Survival analysisSurvival analysis
Survival analysis
 
Introduction To Survival Analysis
Introduction To Survival AnalysisIntroduction To Survival Analysis
Introduction To Survival Analysis
 
1.5.4 measures incidence+incidence density
1.5.4 measures incidence+incidence density1.5.4 measures incidence+incidence density
1.5.4 measures incidence+incidence density
 
Survival Analysis Using SPSS
Survival Analysis Using SPSSSurvival Analysis Using SPSS
Survival Analysis Using SPSS
 
Survival analysis & Kaplan Meire
Survival analysis & Kaplan MeireSurvival analysis & Kaplan Meire
Survival analysis & Kaplan Meire
 
Kaplan meier survival curves and the log-rank test
Kaplan meier survival curves and the log-rank testKaplan meier survival curves and the log-rank test
Kaplan meier survival curves and the log-rank test
 
A gentle introduction to survival analysis
A gentle introduction to survival analysisA gentle introduction to survival analysis
A gentle introduction to survival analysis
 
SURVIVAL ANALYSIS.ppt
SURVIVAL ANALYSIS.pptSURVIVAL ANALYSIS.ppt
SURVIVAL ANALYSIS.ppt
 
Survival analysis
Survival analysisSurvival analysis
Survival analysis
 
2.epidemilogic measures
2.epidemilogic measures2.epidemilogic measures
2.epidemilogic measures
 
Application of survival data analysis introduction and discussion
Application of survival data analysis  introduction and discussionApplication of survival data analysis  introduction and discussion
Application of survival data analysis introduction and discussion
 
Mortality rates & standardization
Mortality rates &  standardizationMortality rates &  standardization
Mortality rates & standardization
 
MANOVA SPSS
MANOVA SPSSMANOVA SPSS
MANOVA SPSS
 
Bias and confounder
Bias and confounderBias and confounder
Bias and confounder
 
Survival analysis 1
Survival analysis 1Survival analysis 1
Survival analysis 1
 
Epidemiology lecture3 incidence
Epidemiology lecture3 incidenceEpidemiology lecture3 incidence
Epidemiology lecture3 incidence
 
Survival Data Analysis for Sekolah Tinggi Ilmu Statistik Jakarta
Survival Data Analysis for Sekolah Tinggi Ilmu Statistik JakartaSurvival Data Analysis for Sekolah Tinggi Ilmu Statistik Jakarta
Survival Data Analysis for Sekolah Tinggi Ilmu Statistik Jakarta
 
unmatched case control studies
unmatched case control studiesunmatched case control studies
unmatched case control studies
 

Similar to Life Tables & Kaplan-Meier Method.pptx

Epidemiology Lectures for UG
Epidemiology Lectures for UGEpidemiology Lectures for UG
Epidemiology Lectures for UG
amitakashyap1
 
Non-Parametric Survival Models
Non-Parametric Survival ModelsNon-Parametric Survival Models
Non-Parametric Survival Models
MangaiK4
 
What is survival analysis, and when should I use it?
What is survival analysis, and when should I use it?What is survival analysis, and when should I use it?
What is survival analysis, and when should I use it?
Cecilia M. Patino-Sutton, MD MeD PhD
 
mudule 3 Measure of health and Health Related Events.pdf
mudule 3 Measure of health and Health Related Events.pdfmudule 3 Measure of health and Health Related Events.pdf
mudule 3 Measure of health and Health Related Events.pdf
teddiyfentaw
 
3. Measures of morbidity(1).pdf
3. Measures of morbidity(1).pdf3. Measures of morbidity(1).pdf
3. Measures of morbidity(1).pdf
SondosAli13
 
Life table and survival analysis 04122013
Life table and survival analysis 04122013Life table and survival analysis 04122013
Life table and survival analysis 04122013
sauravkumar946
 
B04621019
B04621019B04621019
B04621019
IOSR-JEN
 
Medical Surveillance and Outbreaks of Disease.pdf
Medical Surveillance and Outbreaks of Disease.pdfMedical Surveillance and Outbreaks of Disease.pdf
Medical Surveillance and Outbreaks of Disease.pdf
LuckyBoyCount
 
Measuring the occurrences of disease dhanlal
Measuring the occurrences of disease dhanlalMeasuring the occurrences of disease dhanlal
Measuring the occurrences of disease dhanlal
Dhan Pandey
 
Basic epidemiologic concept
Basic epidemiologic conceptBasic epidemiologic concept
Basic epidemiologic concept
mehr92
 
UNIT 3 MEASURES OF FREQUENCY.pdf
UNIT 3 MEASURES OF FREQUENCY.pdfUNIT 3 MEASURES OF FREQUENCY.pdf
UNIT 3 MEASURES OF FREQUENCY.pdf
JoyceSChipili
 
Epidemiology class swati
Epidemiology class swatiEpidemiology class swati
Epidemiology class swati
Swati Sirwar
 
Epidemiology
EpidemiologyEpidemiology
Epidemiology
Mohammed Anis
 
Data and epidemiology 2.pptx
Data and epidemiology 2.pptxData and epidemiology 2.pptx
Data and epidemiology 2.pptx
AbdallahAlasal1
 
Data and epidemiology 2.pptx
Data and epidemiology 2.pptxData and epidemiology 2.pptx
Data and epidemiology 2.pptx
AbdallahAlasal1
 
Basics of Epidemiology and Descriptive epidemiology by Dr. Sonam Aggarwal
Basics of Epidemiology and Descriptive epidemiology by Dr. Sonam AggarwalBasics of Epidemiology and Descriptive epidemiology by Dr. Sonam Aggarwal
Basics of Epidemiology and Descriptive epidemiology by Dr. Sonam Aggarwal
Dr. Sonam Aggarwal
 
Mortality and mobidity indicators
Mortality and mobidity indicatorsMortality and mobidity indicators
Mortality and mobidity indicators
Priyamadhaba Behera
 
Basic measurements in epidemiology
Basic measurements in epidemiologyBasic measurements in epidemiology
Basic measurements in epidemiology
Krupa Mathew
 
Journal Club: 2015 August; START study
Journal Club: 2015 August; START studyJournal Club: 2015 August; START study
Journal Club: 2015 August; START study
Sri Lanka College of Sexual Health and HIV Medicine
 
Cohort, case control & survival studies-2014
Cohort, case control & survival studies-2014Cohort, case control & survival studies-2014
Cohort, case control & survival studies-2014
Ramnath Takiar
 

Similar to Life Tables & Kaplan-Meier Method.pptx (20)

Epidemiology Lectures for UG
Epidemiology Lectures for UGEpidemiology Lectures for UG
Epidemiology Lectures for UG
 
Non-Parametric Survival Models
Non-Parametric Survival ModelsNon-Parametric Survival Models
Non-Parametric Survival Models
 
What is survival analysis, and when should I use it?
What is survival analysis, and when should I use it?What is survival analysis, and when should I use it?
What is survival analysis, and when should I use it?
 
mudule 3 Measure of health and Health Related Events.pdf
mudule 3 Measure of health and Health Related Events.pdfmudule 3 Measure of health and Health Related Events.pdf
mudule 3 Measure of health and Health Related Events.pdf
 
3. Measures of morbidity(1).pdf
3. Measures of morbidity(1).pdf3. Measures of morbidity(1).pdf
3. Measures of morbidity(1).pdf
 
Life table and survival analysis 04122013
Life table and survival analysis 04122013Life table and survival analysis 04122013
Life table and survival analysis 04122013
 
B04621019
B04621019B04621019
B04621019
 
Medical Surveillance and Outbreaks of Disease.pdf
Medical Surveillance and Outbreaks of Disease.pdfMedical Surveillance and Outbreaks of Disease.pdf
Medical Surveillance and Outbreaks of Disease.pdf
 
Measuring the occurrences of disease dhanlal
Measuring the occurrences of disease dhanlalMeasuring the occurrences of disease dhanlal
Measuring the occurrences of disease dhanlal
 
Basic epidemiologic concept
Basic epidemiologic conceptBasic epidemiologic concept
Basic epidemiologic concept
 
UNIT 3 MEASURES OF FREQUENCY.pdf
UNIT 3 MEASURES OF FREQUENCY.pdfUNIT 3 MEASURES OF FREQUENCY.pdf
UNIT 3 MEASURES OF FREQUENCY.pdf
 
Epidemiology class swati
Epidemiology class swatiEpidemiology class swati
Epidemiology class swati
 
Epidemiology
EpidemiologyEpidemiology
Epidemiology
 
Data and epidemiology 2.pptx
Data and epidemiology 2.pptxData and epidemiology 2.pptx
Data and epidemiology 2.pptx
 
Data and epidemiology 2.pptx
Data and epidemiology 2.pptxData and epidemiology 2.pptx
Data and epidemiology 2.pptx
 
Basics of Epidemiology and Descriptive epidemiology by Dr. Sonam Aggarwal
Basics of Epidemiology and Descriptive epidemiology by Dr. Sonam AggarwalBasics of Epidemiology and Descriptive epidemiology by Dr. Sonam Aggarwal
Basics of Epidemiology and Descriptive epidemiology by Dr. Sonam Aggarwal
 
Mortality and mobidity indicators
Mortality and mobidity indicatorsMortality and mobidity indicators
Mortality and mobidity indicators
 
Basic measurements in epidemiology
Basic measurements in epidemiologyBasic measurements in epidemiology
Basic measurements in epidemiology
 
Journal Club: 2015 August; START study
Journal Club: 2015 August; START studyJournal Club: 2015 August; START study
Journal Club: 2015 August; START study
 
Cohort, case control & survival studies-2014
Cohort, case control & survival studies-2014Cohort, case control & survival studies-2014
Cohort, case control & survival studies-2014
 

Recently uploaded

Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
Jim Jacob Roy
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Kosmoderma Academy Of Aesthetic Medicine
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 

Recently uploaded (20)

Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 

Life Tables & Kaplan-Meier Method.pptx

  • 1. Short Talk : Life Table &Kaplan-Meier Method PG Student : Dr.Pravin PG Guide : Dr.Todkar sir Activity Guide : Dr.Jatti sir
  • 2. Purpose 1.There has been short notes on Life Tables & Kaplan-Meier Method in PG exams 2. Short Talk is presented so that all the PGs will be well acquainted with topic
  • 3. Contents : 1.Introduction – Natural history of disease 2. Five approaches of expressing prognosis 3.Life Tables 4.Kaplan-Meier Method
  • 4. Natural History of Disease The disease results from complex interaction between man, an agent ( or cause of disease ) and environment Natural history of disease signifies the way in which a disease evolves over time from the earliest stage of its prepathogenesis phase to termination as recovery, disability or death ,in the absence of treatment or prevention It is described as consisting of two phases : Prepathogenesis (i.e. Process in environment ) & Pathogenesis ( Process in man ) .
  • 5. 1. Prepathogenesis Phase : In this phase the disease agent has not entered the human ,but factors favouring its interaction with human host are already existing in the environment. 2. Pathogenesis phase begins with the entry of disease agent in the susceptible human host .  In case of infectious diseases, the agent multiplies & induces tissue physiological changes ,the disease progresses through period of incubation later through early & late pathogenesis . The final outcome of disease may be recovery disability or death.
  • 7.
  • 8. Natural history of disease in quantitative terms : Importance : 1.To describe severity of disease to establish priorities for clinical services & public health programmes . 2.Quantification is important to establish baseline for natural history , so that as new treatments become available, the effects can be compared. 3. It is important to identify different treatments or management strategies for different stages of disease. 4. Patients are often concerned about prognosis.
  • 9.
  • 10. • Five approaches of expressing prognosis • I. Case-fatality • II. 5-year survival • III. Observed Survival • IV. Median survival Time • V. Relative survival
  • 11. Case- Fatality: • It is defined as the number of people who die of disease by number of people who have the disease • Case Fatality = No. of people who die of disease/ No. of people who have disease× 100
  • 12. Person years It is total sum of number of years that each member in study population is under observation. The individuals are observed for different periods of time ,the unit used for counting the observation time is person –year.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18. Person years : • Limitations: person –years : Each person year is assumed to be equivalent to every other person year (i.e. the risk is same in any person- year observed ) • Despite this issue , Person –years are useful as denominators of rates of events in many situations, as randomized trials , cohort studies
  • 19. Five-Year Survival The 5 –year survival is the percentage of patients who are alive 5 years after treatment begins or 5 years after diagnosis.
  • 20.
  • 21.
  • 22.
  • 23. Median Survival Time:  It is defined as the length of time that half (50%) of the study population survives. Mean survival time is average of survival times Advantages: Median survival time is less affected by extremes , where as mean survival times can be significantly affected by even single outlier In case of median survival , we would only have to observe the deaths of half of the group under observation & in case mean survival have to observe all deaths in study population.
  • 24. Relative survival:  It is defined as the ratio of observed survival in people with the disease to expected survival if the disease were absent.
  • 25. Life Tables (Observed survival ) • The actual observed survival of patients followed over time, based on knowledge the interval within which event has occurred. • Life Tables are used for this purpose • It is peculiar type of cohort analysis.
  • 26. Hypothetical study of Treatment results (2000-2004) Followed to 2005 ( None lost to Follow –Up) Yr of Treat ment No. of Patients treated NO. ALIVE ON ANNIVERSARY OF TREATMENT 2001 2002 2003 2004 2005 2000 84 44 21 13 10 8 2001 62 31 14 10 6 2002 93 50 20 13 2003 60 29 16 2004 76 43
  • 27. • Survival analysis in Patients Treated (2000-2004) Yr of Treat ment No. of Patients treated NO. ALIVE AT END OF YEAR 1st Yr 2nd Yr 3rd Yr 4th Yr 5th Yr 2000 84 44 21 13 10 8 2001 62 31 14 10 6 2002 93 50 20 13 2003 60 29 16 2004 76 43 Total 375 197 71 36 16 8
  • 28. Probability Of Survival For Each Year Of The Study Total no. of patients who were alive 1 year after initiation of treatment / Total number of patients who started treatment 1. Probability of Surviving 1st year (P1) = 197/375 =0.525 2. Probability of Surviving 2nd year (P2) = 71/197-43 = 0.461 3. Probability of Surviving 3rd year (P3) = 36/71-16 = 0.655 4. Probability of Surviving 4th year (P4) = 16/36-13 = 0.696 5. Probability of Surviving 5th year (P5) = 8/16-6 = 0.800
  • 29. Cumulative Probabilities of Surviving Different Lengths of Time : 1. Probability of Surviving 1 year = P1 = 0.525 = 52.5 % 2. Probability of Surviving 2 years = P1×P2 =0.525×0.461 = =0.242 3.Probablity of Surviving 3 years = P1×P2×P3 = 0.525×0.461×0.655 =0.159 4.Probablity of Surviving 4 years = P1×P2×P3×P4 = 0.525×0.461×0.655×0.696 =0.800 5. Probability of Surviving 5 years = P1×P2×P3×P4×P5 = 0.525× 0.461× 0.655 ×0.696 ×0.800 = 0.088
  • 30. • Survival curve for hypothetical example of patients treated from 2000-2004 & followed until 2005
  • 31.
  • 32. Calculating Life Table Interval since beginning treatment Alive at begining of interval Died during interval Withdrew during interval No.at risk of dying during interval Col 2- 1/2 col4 Proportion who died during interval Col3/col5 Proportion who didn’t die during interval 1- Col.6 Cumu lative surviv al x IX dx Wx I’x qx px Px 1st yr 375 178 0 375 0.475 0.525 0.525 2nd yr 197 83 43 175.5 0.473 0.527 0.277 3rd yr 71 19 16 63 0.302 0.698 0.193 4th yr 36 7 13 29.5 0.237 0.763 0.147 5th yr 16 2 6 13 0.154 0.846 0.124
  • 33. • Life Table uses : 1.Finding out expectancy of life at birth or any age 2.Estimating no. of males who can marry and hence become target group for family planning methods Similarly number of children requiring high school education facilities , number of old people requiring social support can be estimated 3.Life insurance companies to fix their premiums and polices. 4.Estimating survival rates after radiotherapy or neurosurgery or anti malignancy treatment in the patients
  • 34. Kaplan –Meier Method Kaplan –Meier method also known as product limit method is statistical method used in analysis of time to event data Kaplan –Meier method is simplest way of computing the survival over time in spite of all difficulties associated with subjects or situations It is one of the best options to be used for measuring the fraction of subjects living after treatment
  • 35. In the Kaplan-Meier method predetermined intervals ,as done in Life tables, are not used. The exact point in time when each death or the event of interest, occurred is identified so that each death or event terminates the previous interval & new interval is started & For this new row is used in the Kaplan- Meier table.  Survival probability for each time interval is calculated as the number of subjects surviving divided by number of patients at risk .
  • 36. • Hypothetical example of study of six patients analyzed by Kaplan-Meier method
  • 37. • Calculating Survival Using Kaplan-Meier Method Times to Deaths from starting Rx (Months ) No. Alive at Each Time of death(Inclu ding those who died at that time) No . Who Died at Each Time Proportion who died at That Time (Col.3/Col.2 ) Proportion who survived at That Time (1-Col.4) Cumulativ e survival 4 6 1 0.167 0.833 0.833 10 4 1 0.250 0.750 0.625 14 3 1 0.333 0.667 0.417 24 1 1 1.000 0.000 0.000
  • 38.
  • 39. Kaplan- Meier Method uses : • It is used to estimate survival function based on time to the occurrence of the event • Life tables are less commonly used nowadays and have been replaced with the Kaplan-Meier method.
  • 40. Assumptions made is using Life tables & Kaplan-Meier Method There has been no change in the effectiveness of treatment or in survivorship over calendar time. Participants are lost to follow up. If large proportion of the study population is lost to follow up, the findings of study will be less valid Third assumption is related with use of predetermined intervals as in case of traditional life tables
  • 41. • References : • 1.Gordis Epidemiology • 2.Park’s Textbook of Preventive & Social Medicine